194 related articles for article (PubMed ID: 16912980)
1. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia.
Ljungberg MC; Bhattacharjee MB; Lu Y; Armstrong DL; Yoshor D; Swann JW; Sheldon M; D'Arcangelo G
Ann Neurol; 2006 Oct; 60(4):420-9. PubMed ID: 16912980
[TBL] [Abstract][Full Text] [Related]
2. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
Miyata H; Chiang AC; Vinters HV
Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
[TBL] [Abstract][Full Text] [Related]
3. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
4. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
[TBL] [Abstract][Full Text] [Related]
5. Developmental lineage of cell types in cortical dysplasia with balloon cells.
Lamparello P; Baybis M; Pollard J; Hol EM; Eisenstat DD; Aronica E; Crino PB
Brain; 2007 Sep; 130(Pt 9):2267-76. PubMed ID: 17711980
[TBL] [Abstract][Full Text] [Related]
6. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia.
Cepeda C; Hurst RS; Flores-Hernández J; Hernández-Echeagaray E; Klapstein GJ; Boylan MK; Calvert CR; Jocoy EL; Nguyen OK; André VM; Vinters HV; Ariano MA; Levine MS; Mathern GW
J Neurosci Res; 2003 May; 72(4):472-86. PubMed ID: 12704809
[TBL] [Abstract][Full Text] [Related]
7. Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex.
Ying Z; Babb TL; Mikuni N; Najm I; Drazba J; Bingaman W
Exp Neurol; 1999 Oct; 159(2):409-18. PubMed ID: 10506512
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia.
André VM; Wu N; Yamazaki I; Nguyen ST; Fisher RS; Vinters HV; Mathern GW; Levine MS; Cepeda C
J Neuropathol Exp Neurol; 2007 Jun; 66(6):491-504. PubMed ID: 17549009
[TBL] [Abstract][Full Text] [Related]
9. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?
Cepeda C; André VM; Vinters HV; Levine MS; Mathern GW
Epilepsia; 2005; 46 Suppl 5():82-8. PubMed ID: 15987258
[TBL] [Abstract][Full Text] [Related]
10. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).
Englund C; Folkerth RD; Born D; Lacy JM; Hevner RF
Acta Neuropathol; 2005 May; 109(5):519-33. PubMed ID: 15877232
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development.
Aronica E; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Gorter JA
Neuroscience; 2007 Mar; 145(1):185-96. PubMed ID: 17207578
[TBL] [Abstract][Full Text] [Related]
12. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
13. Cortical neuronal densities and lamination in focal cortical dysplasia.
Thom M; Martinian L; Sen A; Cross JH; Harding BN; Sisodiya SM
Acta Neuropathol; 2005 Oct; 110(4):383-92. PubMed ID: 16151726
[TBL] [Abstract][Full Text] [Related]
14. Pyramidal cell responses to gamma-aminobutyric acid differ in type I and type II cortical dysplasia.
André VM; Cepeda C; Vinters HV; Huynh M; Mathern GW; Levine MS
J Neurosci Res; 2008 Nov; 86(14):3151-62. PubMed ID: 18615638
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of KCC2 in cortical dysplasia in patients with intractable epilepsy.
Munakata M; Watanabe M; Otsuki T; Nakama H; Arima K; Itoh M; Nabekura J; Iinuma K; Tsuchiya S
Epilepsia; 2007 Apr; 48(4):837-44. PubMed ID: 17284302
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of microtubule-associated protein 2 in large neurons of cortical dysplasia.
Yamanouchi H; Zhang W; Jay V; Becker LE
Ann Neurol; 1996 Jan; 39(1):57-61. PubMed ID: 8572667
[TBL] [Abstract][Full Text] [Related]
17. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cytoarchitecture of cortical dysplasia verified by immunohistochemistry.
Mizoguchi M; Iwaki T; Morioka T; Fukui M; Tateishi J
Clin Neuropathol; 1998; 17(2):100-9. PubMed ID: 9561332
[TBL] [Abstract][Full Text] [Related]
19. Transcription of intermediate filament genes is enhanced in focal cortical dysplasia.
Taylor JP; Sater R; French J; Baltuch G; Crino PB
Acta Neuropathol; 2001 Aug; 102(2):141-8. PubMed ID: 11563628
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons.
Chen TJ; Wang DC; Chen SS
J Neurosci Res; 2009 Aug; 87(10):2297-307. PubMed ID: 19301428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
